Skip to main content
Erschienen in: Journal of Neurology 12/2009

01.12.2009 | Original Communication

Midbrain atrophy in subcortical ischemic vascular dementia

verfasst von: Young-Hee Sung, Ki-Hyung Park, Yeung-Bae Lee, Hyeon-Mi Park, Dong Jin Shin, Jea-Sul Park, Mi-Sun Oh, Hyeo-Il Ma, Kyung-Ho Yu, Suk-Yun Kang, Yun Joong Kim, Byung-Chul Lee

Erschienen in: Journal of Neurology | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

Magnetic resonance imaging (MRI) has revealed age-related changes in midbrain volume in normal subjects. Atrophy of the midbrain in patients with progressive supranuclear palsy (PSP) has been demonstrated using conventional brain MRI, and it was recently reported that some patients with vascular dementia also have midbrain atrophy. The aim of the present study was to investigate if the patients with subcortical ischemic vascular dementia (SIVD) have atrophic changes in the midbrain. MRIs of 23 SIVD patients, 18 probable PSP patients, and 96 controls were retrospectively analyzed. Differences in the distances between midbrain structures were compared across the patient groups and controls. We measured the anteroposterior diameter (AP), and the distance between the interpeduncular fossa and the aqueduct (IF–AQ), the aqueduct and posterior margin of the superior colliculi (AQ–SC), and the peduncular prominence and the interpeduncular fossa (PP–IF) of the midbrain. The AP diameter and IF–AQ were negatively correlated with age in normal controls (r = −0.21, p < 0.005 for AP; r = −0.14, p < 0.0001 for IF–AQ). In SIVD patients, the AP diameter and IF–AQ were both significantly smaller than in controls (p < 0.001). Changes in the midbrain found for SIVD patients were similar to those seen in PSP patients. Our results suggest that the midbrain decreases in size with normal aging, especially around the tegmental region. This change is more pronounced in patients with SIVD and in patients with PSP. Prospective functional studies are needed to ascertain the clinical relevance of midbrain atrophy in SIVD.
Literatur
1.
Zurück zum Zitat Baloh RW, Yue Q, Socotch TM, Jacobson KM (1995) White matter lesions and disequilibrium in older people. I. Case–control comparison. Arch Neurol 52:970–974PubMed Baloh RW, Yue Q, Socotch TM, Jacobson KM (1995) White matter lesions and disequilibrium in older people. I. Case–control comparison. Arch Neurol 52:970–974PubMed
2.
Zurück zum Zitat Bastos Leite AJ, van der Flier WM, van Straaten EC, Scheltens P, Barkhof F (2006) Infratentorial abnormalities in vascular dementia. Stroke 37:105–110CrossRefPubMed Bastos Leite AJ, van der Flier WM, van Straaten EC, Scheltens P, Barkhof F (2006) Infratentorial abnormalities in vascular dementia. Stroke 37:105–110CrossRefPubMed
3.
Zurück zum Zitat Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, Mungas D, Reed BR, Kramer JH, Decarli CC, Weiner MW, Vinters HV (2006) Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol 60:677–687CrossRefPubMed Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, Mungas D, Reed BR, Kramer JH, Decarli CC, Weiner MW, Vinters HV (2006) Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol 60:677–687CrossRefPubMed
4.
Zurück zum Zitat Coffey CE, Wilkinson WE, Parashos IA, Soady SA, Sullivan RJ, Patterson LJ, Figiel GS, Webb MC, Spritzer CE, Djang WT (1992) Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 42:527–536PubMed Coffey CE, Wilkinson WE, Parashos IA, Soady SA, Sullivan RJ, Patterson LJ, Figiel GS, Webb MC, Spritzer CE, Djang WT (1992) Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 42:527–536PubMed
5.
Zurück zum Zitat De Reuck J, Siau B, Decoo D, Santens P, Crevits L, Strijckmans K, Lemahieu I (2001) Parkinsonism in patients with vascular dementia: clinical, computed- and positron emission-tomographic findings. Cerebrovasc Dis 11:51–58CrossRefPubMed De Reuck J, Siau B, Decoo D, Santens P, Crevits L, Strijckmans K, Lemahieu I (2001) Parkinsonism in patients with vascular dementia: clinical, computed- and positron emission-tomographic findings. Cerebrovasc Dis 11:51–58CrossRefPubMed
6.
Zurück zum Zitat Dommic P, Shona P, Marjan J, Andrew L, Nick F (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129:1040–1049CrossRef Dommic P, Shona P, Marjan J, Andrew L, Nick F (2006) Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 129:1040–1049CrossRef
7.
Zurück zum Zitat Doraiswamy PM, Na C, Husain MM, Figiel GS, McDonald WM, Ellinwood EH Jr, Boyko OB, Krishnan KR (1992) Morphometric changes of the human midbrain with normal aging: MR and stereologic findings. AJNR Am J Neuroradiol 13:383–386PubMed Doraiswamy PM, Na C, Husain MM, Figiel GS, McDonald WM, Ellinwood EH Jr, Boyko OB, Krishnan KR (1992) Morphometric changes of the human midbrain with normal aging: MR and stereologic findings. AJNR Am J Neuroradiol 13:383–386PubMed
8.
Zurück zum Zitat Dubinsky RM, Jankovic J (1987) Progressive supranuclear palsy and a multi-infarct state. Neurology 37:570–576PubMed Dubinsky RM, Jankovic J (1987) Progressive supranuclear palsy and a multi-infarct state. Neurology 37:570–576PubMed
9.
Zurück zum Zitat Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 59:23–30PubMed Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 59:23–30PubMed
10.
Zurück zum Zitat Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356PubMed Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356PubMed
11.
Zurück zum Zitat Geula C, Schatz CR, Mesulam MM (1993) Differential localization of NADPH-diaphorase and calbindin-D28 k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience 54:461–476CrossRefPubMed Geula C, Schatz CR, Mesulam MM (1993) Differential localization of NADPH-diaphorase and calbindin-D28 k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience 54:461–476CrossRefPubMed
12.
Zurück zum Zitat Jellinger K (1988) The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 51:540–543CrossRefPubMed Jellinger K (1988) The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 51:540–543CrossRefPubMed
13.
Zurück zum Zitat Jellinger K (1971) Progressive supranuclear palsy (subcortical argyrophilic dystrophy). Acta Neuropathol 19:347–352CrossRefPubMed Jellinger K (1971) Progressive supranuclear palsy (subcortical argyrophilic dystrophy). Acta Neuropathol 19:347–352CrossRefPubMed
14.
Zurück zum Zitat Jerzy S, Akiko I, Ryan U, Robert P, Andrey S, Dennis D, Daniel B, Zbigniew W (2008) MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 255:37–44 Jerzy S, Akiko I, Ryan U, Robert P, Andrey S, Dennis D, Daniel B, Zbigniew W (2008) MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 255:37–44
15.
Zurück zum Zitat Josef P, Gary W, Antonio D (2000) Selective pathological changes of the periaqueductal gray matter in Alzhemier’s disease. Ann Neurol 48:344–353CrossRef Josef P, Gary W, Antonio D (2000) Selective pathological changes of the periaqueductal gray matter in Alzhemier’s disease. Ann Neurol 48:344–353CrossRef
16.
Zurück zum Zitat Juncos JL, Hirsch EC, Malessa S, Duyckaerts C, Hersh LB, Agid Y (1991) Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 41:25–30PubMed Juncos JL, Hirsch EC, Malessa S, Duyckaerts C, Hersh LB, Agid Y (1991) Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 41:25–30PubMed
17.
Zurück zum Zitat Kato N, Arai K, Hattori T (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210:57–60CrossRefPubMed Kato N, Arai K, Hattori T (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210:57–60CrossRefPubMed
18.
Zurück zum Zitat Lee MS, Rinne JO, Marsden CD (2000) The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med J 41:167–184PubMed Lee MS, Rinne JO, Marsden CD (2000) The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med J 41:167–184PubMed
19.
Zurück zum Zitat Lee PH, Yong SW, Ahn YH, Huh K (2005) Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus. J Neurol 252:958–963CrossRefPubMed Lee PH, Yong SW, Ahn YH, Huh K (2005) Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus. J Neurol 252:958–963CrossRefPubMed
20.
Zurück zum Zitat Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486CrossRefPubMed Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486CrossRefPubMed
21.
Zurück zum Zitat Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D’Olhaberriague L (1997) Which clinical features differentiate progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) from related disorders? A clinicopathological study. Brain 120(Pt 1):65–74CrossRefPubMed Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D’Olhaberriague L (1997) Which clinical features differentiate progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) from related disorders? A clinicopathological study. Brain 120(Pt 1):65–74CrossRefPubMed
22.
Zurück zum Zitat Luft AR, Skalej M, Schulz JB, Welte D, Kolb R, Burk K, Klockgether T, Voight K (1999) Patterns of age-related shrinkage in cerebellum and brainstem observed in vivo using three-dimensional MRI volumetry. Cereb Cortex 9:712–721CrossRefPubMed Luft AR, Skalej M, Schulz JB, Welte D, Kolb R, Burk K, Klockgether T, Voight K (1999) Patterns of age-related shrinkage in cerebellum and brainstem observed in vivo using three-dimensional MRI volumetry. Cereb Cortex 9:712–721CrossRefPubMed
23.
Zurück zum Zitat Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC (1995) Binswanger’s disease presenting as levodopa-responsive Parkinsonism: clinicopathologic study of three cases. Mov Disord 10:450–454CrossRefPubMed Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC (1995) Binswanger’s disease presenting as levodopa-responsive Parkinsonism: clinicopathologic study of three cases. Mov Disord 10:450–454CrossRefPubMed
24.
Zurück zum Zitat Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64:2050–2055CrossRefPubMed Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64:2050–2055CrossRefPubMed
25.
Zurück zum Zitat Olszewski J, Baxter D (1982) Cytoarchitecture of the human brainstem. Karger, Basel Olszewski J, Baxter D (1982) Cytoarchitecture of the human brainstem. Karger, Basel
26.
Zurück zum Zitat Pahapill PA, Lozano AM (2000) The pedunculopontine nucleus and Parkinson’s disease. Brain 123(Pt 9):1767–1783CrossRefPubMed Pahapill PA, Lozano AM (2000) The pedunculopontine nucleus and Parkinson’s disease. Brain 123(Pt 9):1767–1783CrossRefPubMed
27.
Zurück zum Zitat Righini A, Antonini A, De Notaris R, Bianchini E, Meucci N, Sacilotto G, Canesi M, De Gaspari D, Triulzi F, Pezzoli G (2004) MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 25:927–932PubMed Righini A, Antonini A, De Notaris R, Bianchini E, Meucci N, Sacilotto G, Canesi M, De Gaspari D, Triulzi F, Pezzoli G (2004) MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 25:927–932PubMed
28.
Zurück zum Zitat Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, Quinn NP (2000) Differentiation of atypical Parkinsonian syndromes with routine MRI. Neurology 54:697–702PubMed Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, Quinn NP (2000) Differentiation of atypical Parkinsonian syndromes with routine MRI. Neurology 54:697–702PubMed
30.
Zurück zum Zitat Skinner RD, Garcia-Rill E (1984) The mesencephalic locomotor region (MLR) in the rat. Brain Res 323:385–389CrossRefPubMed Skinner RD, Garcia-Rill E (1984) The mesencephalic locomotor region (MLR) in the rat. Brain Res 323:385–389CrossRefPubMed
31.
Zurück zum Zitat Sohmiya M, Tanaka M, Aihara Y, Hirai S, Okamoto K (2001) Age-related structural changes in the human midbrain: an MR image study. Neurobiol Aging 22:595–601CrossRefPubMed Sohmiya M, Tanaka M, Aihara Y, Hirai S, Okamoto K (2001) Age-related structural changes in the human midbrain: an MR image study. Neurobiol Aging 22:595–601CrossRefPubMed
32.
Zurück zum Zitat Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A. Heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333–359PubMed Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A. Heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333–359PubMed
33.
Zurück zum Zitat Thompson PD, Marsden CD (1987) Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger’s disease. Mov Disord 2:1–8CrossRefPubMed Thompson PD, Marsden CD (1987) Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger’s disease. Mov Disord 2:1–8CrossRefPubMed
34.
Zurück zum Zitat Tolosa ES, Santamaria J (1984) Parkinsonism and basal ganglia infarcts. Neurology 34:1516–1518PubMed Tolosa ES, Santamaria J (1984) Parkinsonism and basal ganglia infarcts. Neurology 34:1516–1518PubMed
35.
Zurück zum Zitat Warmuth-Metz M, Naumann M, Csoti I, Solymosi L (2001) Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 58:1076–1079CrossRefPubMed Warmuth-Metz M, Naumann M, Csoti I, Solymosi L (2001) Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 58:1076–1079CrossRefPubMed
36.
Zurück zum Zitat Winikates J, Jankovic J (1994) Vascular progressive supranuclear palsy. J Neural Transm Suppl 42:189–201PubMed Winikates J, Jankovic J (1994) Vascular progressive supranuclear palsy. J Neural Transm Suppl 42:189–201PubMed
37.
Zurück zum Zitat Winikates J, Jankovic J (1999) Clinical correlates of vascular Parkinsonism. Arch Neurol 56:98–102CrossRefPubMed Winikates J, Jankovic J (1999) Clinical correlates of vascular Parkinsonism. Arch Neurol 56:98–102CrossRefPubMed
38.
Zurück zum Zitat Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL (1989) The pedunculopontine nucleus in Parkinson’s disease. Ann Neurol 26:41–46CrossRefPubMed Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL (1989) The pedunculopontine nucleus in Parkinson’s disease. Ann Neurol 26:41–46CrossRefPubMed
39.
Zurück zum Zitat Zweig RM, Whitehouse PJ, Casanova MF, Walker LC, Jankel WR, Price DL (1987) Loss of pedunculopontine neurons in progressive supranuclear palsy. Ann Neurol 22:18–25CrossRefPubMed Zweig RM, Whitehouse PJ, Casanova MF, Walker LC, Jankel WR, Price DL (1987) Loss of pedunculopontine neurons in progressive supranuclear palsy. Ann Neurol 22:18–25CrossRefPubMed
Metadaten
Titel
Midbrain atrophy in subcortical ischemic vascular dementia
verfasst von
Young-Hee Sung
Ki-Hyung Park
Yeung-Bae Lee
Hyeon-Mi Park
Dong Jin Shin
Jea-Sul Park
Mi-Sun Oh
Hyeo-Il Ma
Kyung-Ho Yu
Suk-Yun Kang
Yun Joong Kim
Byung-Chul Lee
Publikationsdatum
01.12.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
Journal of Neurology / Ausgabe 12/2009
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5226-z

Weitere Artikel der Ausgabe 12/2009

Journal of Neurology 12/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.